The global cell line development market is witnessing remarkable growth, driven by its critical role in advancing biomedical research and therapeutic development. Valued at approximately US$ 140 million in 2022, the market is projected to expand at a compound annual growth rate (CAGR) of 9.64%, reaching an estimated US$ 16.28 billion by 2032. This surge is fueled by increasing applications in...